Navigation Links
Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression

Researchers have found that Migration/Macrophage Inhibitory factor (MIF) which is an immune cell responsible for progression of Multiple Sclerosis. This new pathway can be used in finding drugs which reduces the amount of MIF // in a way progression of Multiple Sclerosis is hindered.

Multiple Sclerosis:

Multiple Sclerosis is an autoimmune disease which is caused by non-recognizing of its own body cells by the immune system leading to an immune response of activating immune cells against the body’s own cells. In Multiple Sclerosis the immune cells produces an immune response against the myelin sheath that surrounds nerve fibers in the brain and spinal cord and enables them to transmit impulses. MS shows a pattern of remission and relapse with no warning as to when a relapse will occur.

Migration Inhibiton Factor – Multiple Sclerosis:

Professor Caroline Whitacre and team from Ohio State University have found that Migration/Macrophage Inhibition Factor stimulates a chain of reactions that lead to the production of inflammation-producing chemicals. Conversely, lack of MIF seems to trigger the release of other immune system chemicals that block inflammation.

Researchers are confident that blocking the molecule macrophage migration inhibitory factor it will be possible for treatment of Multiple Sclerosis.

Experts View:

Professor Caroline Whitacre said, "Our results suggest that MIF may be less important for initiating MS, but that it may be necessary for MS progression and the levels of MIF can be used as an indicator of multiple sclerosis disease progression. But more importantly, perhaps this study will lead to drugs that can halt the course of MS by blocking the action of MIF."

Mike O'Donovan, chief executive Multiple Sclerosis Society said, "The possibility that a way might be found to stop MS in its tracks is obviously encouraging and needs investigating further.

Helen Yates, Multiple Sclerosis Resource Centre said, "Whilst this study is only at the animal model stage, the identification of this potential gene factor in relation to MS is extremely interesting and offers great hope for the future."

Source: BBC News.
'"/>




Related medicine news :

1. Lymph Cell Growth In Eyes Related To Macrophages
2. Risk Factors for vision problems in Diabetes
3. Age-Related Macular Degeneration - Risk Factors
4. Factors That Might Increase The Risk Of Schizophrenia
5. Evaluating The Risk Factors Of Osteoporosis
6. Elevated Blood Sugar Levels A Risk Factor Of Heart Disease
7. Obesity A Risk Factor For Stroke
8. Risk Factors For Stroke Studied
9. Analyzing The Risk Factors For Diabetic Neuropathy
10. Heart Disease Risk Factors Found To Increase Risk of Dementia In Old Age
11. Environmental Factors Found To Have An Impact On The Sex of A Child
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: